Follow
J. Peter Marquardt
J. Peter Marquardt
Research Fellow, Massachusetts General Hospital/Harvard Medical School
Verified email at mgh.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Multilevel body composition analysis on chest computed tomography predicts hospital length of stay and complications after lobectomy for lung cancer: a multicenter study
TD Best, SF Mercaldo, DS Bryan, JP Marquardt, MM Wrobel, CP Bridge, ...
Annals of surgery 275 (5), e708-e715, 2022
272022
A Fully Automated Deep Learning Pipeline for Multi–Vertebral Level Quantification and Characterization of Muscle and Adipose Tissue on Chest CT Scans
CP Bridge, TD Best, MM Wrobel, JP Marquardt, K Magudia, C Javidan, ...
Radiology: Artificial Intelligence 4 (1), e210080, 2022
182022
Muscle loss is associated with overall survival in patients with metastatic colorectal cancer independent of tumor mutational status and weight loss
TD Best, EJ Roeland, NK Horick, EE Van Seventer, A El-Jawahri, ...
The Oncologist 26 (6), e963-e970, 2021
142021
Percentile‐based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels
JP Marquardt, EJ Roeland, EE Van Seventer, TD Best, NK Horick, ...
Journal of Cachexia, Sarcopenia and Muscle 13 (1), 190-202, 2022
132022
Significance of acquisition parameters for adipose tissue segmentation on CT images
AS Troschel, FM Troschel, G Fuchs, JP Marquardt, JB Ackman, K Yang, ...
American Journal of Roentgenology 217 (1), 177-185, 2021
132021
Associations of skeletal muscle with symptom burden and clinical outcomes in hospitalized patients with advanced cancer
E van Seventer, JP Marquardt, AS Troschel, TD Best, N Horick, C Azoba, ...
Journal of the National Comprehensive Cancer Network 19 (3), 319-327, 2021
132021
Machine learning in body composition analysis
MI Higgins, JP Marquardt, VA Master, FJ Fintelmann, SP Psutka
European Urology Focus 7 (4), 713-716, 2021
112021
Utility of noncancerous chest CT features for predicting overall survival and noncancer death in patients with stage I lung cancer treated with stereotactic body radiotherapy
I Tahir, JP Marquardt, ND Mercaldo, PP Bourgouin, MM Wrobel, S Mrah, ...
American Journal of Roentgenology 219 (4), 579-589, 2022
82022
Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events
A Phuong, JP Marquardt, R O'Malley, SK Holt, G Laidlaw, Z Eagle, S Ngo, ...
Urologic Oncology: Seminars and Original Investigations 40 (10), 456. e19 …, 2022
32022
Intermuscular adiposity is associated with coronary microvascular dysfunction independently of body mass index and modifies its effect on adverse cardiovascular outcomes
AC Souza, T Amelie S, M Jan P, M Filipe A, D Sanjay, H Jon, B Ron, ...
medRxiv, 2023.05. 03.23289408, 2023
12023
Factors Associated with Hospital Length of Stay and Adverse Events following Percutaneous Ablation of Lung Tumors
I Tahir, AM Cahalane, JA Saenger, KS Leppelmann, MA Kashani, ...
Journal of Vascular and Interventional Radiology 34 (5), 759-767. e2, 2023
12023
Changes in body composition during neoadjuvant platinum-based chemotherapy associations prior to radical cystectomy: Implications for chemotherapy-associated adverse events and …
R Maldonado, FJ Fintelmann, JP Marquardt, RB O'Malley, SK Holt, S Ngo, ...
Journal of Clinical Oncology 40 (6_suppl), 476-476, 2022
12022
Associations of sarcopenia with hematologic toxicity, treatment intensity, and healthcare utilization in patients with metastatic colorectal cancer.
M Lei, RD Nipp, E Tavares, U Lou, E Grasso, SY Mui, JP Marquardt, ...
Journal of Clinical Oncology 40 (4_suppl), 84-84, 2022
12022
MP14-13 EVALUATING BASELINE AND CHANGE IN BODY COMPOSITION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA WITH FRONT-LINE SYSTEMIC THERAPY: IMPLICATIONS FOR ADVERSE EVENTS …
D Orcutt, MM Wrobel, S Mrah, JP Marquardt, F Fintelmann, D Hussey, ...
The Journal of Urology 206 (Supplement 3), e258-e258, 2021
12021
Intermuscular fat is independently associated with coronary microvascular dysfunction and adverse cardiovascular outcomes in patients with no obstructive CAD
ACA Souza, AS Troschel, JP Marquardt, S Divakaran, J Brown, L Barrett, ...
Circulation 142 (Suppl_3), A14657-A14657, 2020
12020
Relationships among skeletal muscle, symptom burden, health care use, and survival in hospitalized patients with advanced cancer.
CC Azoba, EE Van Seventer, JP Marquardt, AS Troschel, TD Best, ...
Journal of Clinical Oncology 38 (15_suppl), 7006-7006, 2020
12020
MP50-14 A MULTICENTER EVALUATION OF THE PROGNOSTIC UTILITY OF CHANGES IN TREATMENT-ASSOCIATED BODY COMPOSITION IN MEN WITH GERM CELL TUMORS (GCT) OF THE TESTIS: IMPLICATIONS …
C Buxton, BN Schmeusser, SK Holt, D Patil, A Phuong, JP Marquardt, ...
The Journal of Urology 209 (Supplement 4), e690, 2023
2023
MP56-06 ASSOCIATIONS BETWEEN SKELETAL MUSCLE GAUGE AND SURVIVAL FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER: A NOVEL ASSESSMENT OF MUSCLE MASS AND QUALITY
M Noonavath, K Mun, JP Marquardt, FJ Fintelmann, R O'Malley, SK Holt, ...
The Journal of Urology 207 (Supplement 5), e973, 2022
2022
MP46-12 DECLINES IN SKELETAL MUSCLE MASS AND QUALITY DURING CYTOTOXIC CHEMOTHERAPY PREDICT INCREASED RISK OF CHEMOTHERAPY-ASSOCIATED ADVERSE EVENTS IN MEN WITH TESTIS CANCER
A Phuong, JP Marquardt, FJ Fintelmann, R O'Malley, G Laidlaw, Z Eagle, ...
The Journal of Urology 207 (Supplement 5), e777, 2022
2022
Body Composition on Chest Computed Tomography Predicts Hospital Length of Stay and Complications Following Lobectomy for Lung Cancer: A Multicenter Study
F Fintelmann, TD Best, SF Mercaldo, JP Marquardt, A Muniappan, ...
B110. IMAGING AND MOLECULAR BIOMARKERS FOR LUNG CANCER, A4446-A4446, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20